The number of people who dread and even fear going to the dentist is quite remarkable. Even individuals who feel they have a high pain threshold will only go to the dentist when absolutely neccessary. There are many factors that contribute to dental anxiety. However, dentists are now using quality dental management to create a calm and pleasant experience for their patients.

Avoiding dental treatment due to fear and anxiety can lead to serious problems. Regular check-ups including cleanings keep the mouth, gums and teeth in great overall health. Conditions like gingivitis can be treated when detected early. Other issues such as cavities, gum disease and even bad breath can be addressed by a dentist. These prevenative visits will also curtail any potentially painful issues that may arise in the future. Seeing the dentist for these easy and painless visits can prevent a patient from having to go during a sudden, painful toothache or other episode.

Pain management within the dental office has come a long way from the simple methods of years ago. Nervous patients now have the option of sedation dentistry. This process can be accomplished through several methods. Oral medications such as Valium can be used prior to a dental visit to relax an individual. Certain medications can also be given intravenously if needed to produce the same effect. During light sedation, the patient is awake and aware of their surroundings.

Most people have heard of “laughing gas” or as it is medically known, nitrous oxide. This harmless gas can be administered through a mask in the office within a matter of minutes. The patient will relax and even be overcome with a sense of elevated happiness or joy. This elation takes the place of fear and helps individuals go through their dental visit without much knowledge of the actual procedure.

Deep sedation can be performed by dentists who have received specialized training as well as certifications from their state. This method includes the use of stronger intravenous drugs and allows the patient to sleep. Close monitoring is required during this type of sedation. Some professionals will also offer general anesthesia. This is the same process used to put individuals to sleep during surgery. This anesthesia also requires close and constant monitoring as it may affect the way a patient breathes during their procedure.

The proper form of pain management depends on several key factors. These include the type of procedure being done, the patients medical history and the overall mental state of the individual. It is important for the dental team to have a detailed conversation with the patient to determine their anxiety level and previous dental experiences.

Patients who have a fear of the dentist do have options for a comfortable and easy experience. Individuals should consult with their dental professionals to verify their certifications and find out the sedation options that are offered. Having a clear understanding of the proposed procedures and the options for pain management will ensure that a dental visit is as pleasant as possible.

In a recent issue of the Journal Of The American Dental Association or ADA it is reported that the majority of dentists working as a children dentist over-prescribe antibiotics to their patients.

The study found a 10%-42% prescribing guideline adherence from the 154 North Carolina dentists surveyed in the way they would treat hypothetical cases.

The Medscape Medical News was told by the corresponding author of the article Jessica Y. Lee, DDS, MPH that she was surprised the figure was that low.

Dr. Lee, a University of North Carolina pediatric dentistry associate professor said antibiotics were prescribed when the guidelines indicated they were not in fact necessary by the dentists.

Her warnings were that there can be severe allergic reactions and one can also develop organisms that makes them develop reistance to antibiotics.

Every year approximately 10% of the antibiotic prescriptions in the U.S. are written by dentists. That 10% translates into somewhere between 200 and 300 million.

The survey was formulated around how respondents would prescribe antibiotics under various scenarios involving patients and whatever their symptoms were.

Of the 154 respondents to the survey 48 were involved in pediatric dentistry while the rest (106) were involved in general dentistry.

The responses were compared by the researchers with guidelines provided by both the ADA and the AAPD whose guidelines were the more specific of the two organizations.

The first hypothetical case involved the right primary second molar with a deep carious lesion. Respondents were asked what would lead them to prescribe antibiotics: local swelling and pain without radiographic proof of pathology, local swelling and pain symptoms with radiographic pathology evidence and facial swelling and pain symptoms also with radiographic pathology evidence.

The professional guidelines of the AAPD say antibiotics should be prescribed by the dentist when there is radiographic pathology evidence or facial swelling with pain or without it.

The bad news is that the correct answer came from only 26% of the respondents. 24% of the general dentists adhered to the guidelines as well as 31% of the pediatric dentists.

The addition of fever to the symptoms resulted in the overall adherence lowering to 12%. Removal of fever and addition of local swelling changed the adherence number to 32%.

Less than 25% of the dentists surveyed reported they would have to see the patient to prescribe antibiotics. Many said they would be willing to prescribe them over the phone which leads to concerns of antibiotic overuse.

The survey also showed that those dentists that see 15 or more children every week would be more likely to hand prescriptions out as would rural dentists. Those who had been through advanced education and training were less likely to hand out prescriptions freely.

Dr. Lee continually emphasizes the need for guideline that are more specific and the professional groups efforts to be certain they are understood by the dentists.

Commenting on the study Paul Casamassimo, DDS, pointed out that the majority of those involved in the study had graduated from the University of North Carolina shedding doubt then that the findings were reflective of all dentists.

Additionally he expressed little surprise saying he had observed similar results in medical physicians surveys.

He additionally expressed he did not regard it as a major concern that many pediatricians are forced into satisfying patients by giving them antibiotics. He also commented his belief that dentists seeing many kids practice a defensive type dentistry.

His final observation was concerning the lack of research regarding antibiotic effectiveness in the dentistry field. This contributes to the typical dentist not seeing the harm in antibiotic overusage.

In current drug news, the pharmaceutical industry may be seeing an approval from the US Food and Drug Administration for cannibis-derived drugs quite soon. The first FDA-approved drugs containing marijuana components were actually approved about 25 years ago, but it’s the newer variation that may line the shelves of pharmacies across the country.

The research of GW Pharma (based in the UK) played a pivotal role in the initiative. They are currently completing the first advanced trials for a marijuana-drug developed as a mouth spray that alleviates pain for cancer sufferers. The release year for the drug is tentatively slated for 2014. Their exemption from the British government to harvest cannibis for the company’s marijuana and health research made development of the drug possible.

Another of their pot derivatives developed to relieve MS-related muscle spams, Sativex, has received the approval of at least ten countries. The National MS Society is sponsoring a neurologist at UC Davis’ comparison study trials on the effect of Marinol to reduce spasms in medical marijuana smokers.

Already legal in 16 of the 50 states, cannibis usage still faces controversial classification by drug enforcement agencies. It will be interesting to see how the federal levels of government approach the contradictions of their inter-departmental definitions.

On Thursday, a watchdog organization urged the FDA to have a new vote about the risk of blood clots caused by birth control pills after agency advisers learned that the agency has ties to pill manufacturers. In December, the FDA asked experts to talk about the safety of birth control pills that contain the ingredient drospirenone. The Bayer birth control pills Yasmin and Yaz contain the potentially harmful compound. The panel made the decision that the benefits of pregnancy prevention outweighed any risks of the development of blood clots. According to public and court documents, three of the 26 FDA advisers had financial or research ties to the Bayer Company.

A fourth adviser was connected to the producer of generic copies of Yaz, Barr Lab, which is now a part of the Teva Pharmaceuticals Company. All four advisers’ votes reflected their beliefs that the birth control pill’s benefits outweighed any possible risks, which according to the Project on Government Oversight means that the pills could possibly stay on the market. The FDA does not have any obligation to follow recommendations made by its advisers but it often does which leads to questions about who is providing the advice.

The Executive Director of POGO, Danielle Brian said that American consumers should be able to trust the FDA and have faith that the advisory boards make decisions based on scientific facts rather than industry influence. The group delivered a letter to the Commissioner of the FDA, Margaret Hamburg this week. The letter asked Hamburg to throw out the old vote and assemble a new advisory committee to review the pills’ safety.

One FDA study estimated that ten out of ever ten thousand women who took birth control pills that included drospirenone would develop a blood clot per year in comparison to the six in ten thousand women that take older contraceptive brands. A blood vessel clot can be fatal if it reaches the heart, lungs or brain.

Some consumer organizations have urged the FDA to remove the pills in question from the market, since women have so many other control birth products available to them. David Kessler, the former head of the FDA has said that Bayer did not reveal blood clot reports from the agency and failed to warn patients about possible safety problems. During the December meeting, FDA advisers said that the scientific proof was inconclusive regarding the higher rate of blood clot incidence, but they did recommend that a better safety label be placed on the pills. A safety label that included all possible side effects would be a step in the right direction although removal of the product would be even better.

To some people it seems like just about every cent they make goes right to the pharmacy. The prescription prices are on the rise and so are out of pocket expenses.
One city is making a change by offering up new prescription cards, aimed at getting discounts from the big name pharmacies.
Officials in Carbondale claim that more than twenty percent can be saved at large pharmacies on some prescriptions by using the discount card.
This is driving the smaller pharmacies to offer similar deals in attempt to keep their business.
There is no reason why anybody should want to ignore the savings that can be provided by such a card.

This opportunity was provided to Carbondale because it is a Nation League of Cities member. The target are prescriptions that insurance does not cover or has limited coverage over and includes CVS/Caremark chains in over four hundred fifty cities around the nation.
Another great way to save money is to go with the generic labels of the medications that you need. IT is the same medication as the major brands at a much more reasonable price.

The discount cards are nothing new, but are a good way to keep a competitive market in the pharmaceutical industry. You do not need to be from any particular city to pick up one of these discount cards. They work at many locations across the country.

A study done by the Yale University School of Medicine showed that elderly people who do not brush their teeth regularly are at an increased risk for pneumonia. Dr. Samit Joshi, who is a professor at the school stated that the bacteria in the mouth can cause diseases of lungs.

Pneumonia is a condition that affects about 620,000 people in the United Kingdom. Approximately 5 percent of the people affected die as a result of this condition.

It is important to note that more research is needed to be done to determine the exact relationship between pneumonia and oral health. However, it is not the first time that the diseases have been linked together.

People have associated poor oral health with respiratory diseases for several years. Many believe that bacteria chest infections are caused by breathing the droplets from the mouth and the throat into the lungs.

This can not only worsen an existing infection, but it can also cause pneumonia. Studies have also shown that people who have periodontal gum disease also have a higher mortality rate. Elderly and young people are at the greatest risk according to Dr. Nigel Carter, who is the chief executive for the British Dental Foundation.

Dr. Carter stated that people more susceptible to coughs, chesty viruses and colds during the winter because of the drop in temperature. He also stated that it is very easy to prevent gum problems. He recommends brushing for at least two minutes ever single day and flossing once a day. He also recommends that people reduce their intake of sugary beverages and foods and visit their dentist on a regular basis. Bad breath, loose teeth and bleeding gums are some of the signs of gum disease. If those symptoms persist, people should see their dentists for gum disease and treatment